These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1358253)

  • 1. Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.
    Kaiser FC; Palmer GC; Wallace AV; Carr RD; Fraser-Rae L; Hallam C
    Neuroreport; 1992 Oct; 3(10):922-4. PubMed ID: 1358253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.
    Shepherd J; Bill DJ; Dourish CT; Grewal SS; McLenachan A; Stanhope KJ
    Psychopharmacology (Berl); 1996 Aug; 126(3):206-18. PubMed ID: 8876020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Nafrialdi E; Mimran A
    J Hypertens Suppl; 1991 Dec; 9(6):S210-1. PubMed ID: 1818949
    [No Abstract]   [Full Text] [Related]  

  • 5. DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum.
    Dwoskin LP; Jewell AL; Cassis LA
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):153-9. PubMed ID: 1314959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan influences behavioural effects of angiotensin II in rats.
    Kułakowska A; Karwowska W; Wiśniewski K; Braszko JJ
    Pharmacol Res; 1996; 34(3-4):109-15. PubMed ID: 9051700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
    Batin P; Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist.
    Barnes NM; Costall B; Kelly ME; Murphy DA; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):20-1. PubMed ID: 1983352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm.
    Barnes NM; Champaneria S; Costall B; Kelly ME; Murphy DA; Naylor RJ
    Neuroreport; 1990; 1(3-4):239-42. PubMed ID: 2129885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
    Dourish CT; Duggan JA; Banks RJ
    Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
    Song KF; Zhuo JL; Mendelsohn FA
    Br J Pharmacol; 1991 Dec; 104(4):771-2. PubMed ID: 1810594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
    Bui JD; Kimura B; Phillips MI
    Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

  • 19. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of DUP-753 on the drinking responses of rats to central administration of noradrenaline and angiotensin II and to dehydration.
    Reis LC; Saad WA; Camargo LA; Renzi A; Menani V; Silveira JE; Saad WA
    Braz J Med Biol Res; 1996 Apr; 29(4):507-10. PubMed ID: 8736116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.